As the deadline for publishing the fifth quantitative impact study approached in March, insurers could have been forgiven for thinking this would produce bad news. If the test run suggested a ramping up of capital at a time when the investor base for financial paper is hardly ravenous, problems could have been on the horizon.
But, crucially, this has not happened. In fact by dint of using an internal model, a large diversified group will end up on capital levels almost identical to their Solvenc
The week on Risk.net, July 14–20, 2017Receive this by email